Nationwide Fund Advisors - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 141 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$360,000
+8.1%
50,732
+10.2%
0.00%0.0%
Q2 2017$333,000
+17.7%
46,0180.0%0.00%0.0%
Q1 2017$283,000
-2.7%
46,018
-7.3%
0.00%0.0%
Q4 2016$291,000
+5.4%
49,640
-4.6%
0.00%0.0%
Q3 2016$276,000
-19.8%
52,0100.0%0.00%0.0%
Q2 2016$344,000
+11.7%
52,010
-21.0%
0.00%0.0%
Q1 2016$308,000
-11.2%
65,868
-4.2%
0.00%0.0%
Q4 2015$347,000
+47.0%
68,725
+2.6%
0.00%0.0%
Q3 2015$236,000
-64.7%
66,9760.0%0.00%
-66.7%
Q2 2015$668,000
-29.2%
66,976
-9.6%
0.00%
-25.0%
Q1 2015$943,000
-4.1%
74,077
+6.7%
0.00%0.0%
Q4 2014$983,000
+1.7%
69,439
-1.3%
0.00%0.0%
Q3 2014$967,000
-10.5%
70,342
+0.1%
0.00%0.0%
Q2 2014$1,081,000
-78.9%
70,288
-76.6%
0.00%
-83.3%
Q1 2014$5,122,000
+84.0%
300,581
+39.8%
0.02%
+100.0%
Q4 2013$2,783,000
+324.2%
214,939
+230.8%
0.01%
+300.0%
Q3 2013$656,000
+42.3%
64,985
+5.3%
0.00%
+50.0%
Q2 2013$461,00061,7020.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Finepoint Capital LP 1,605,800$16,026,0004.65%
Baupost Group 25,791,678$257,401,0004.29%
1492 Capital Management LLC 264,297$2,638,0001.67%
Cormorant Asset Management, LP 826,000$8,243,0001.10%
FALCON POINT CAPITAL, LLC 251,137$2,506,0000.85%
OAK RIDGE INVESTMENTS LLC 3,291,711$32,851,0000.70%
Knoll Capital Management, LLC 200,000$1,996,0000.64%
Rhenman & Partners Asset Management AB 534,000$5,329,0000.64%
Old West Investment Management, LLC 79,667$795,0000.55%
THREE BAYS CAPITAL LP 1,284,000$12,814,0000.53%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders